10-Panel Pipette Drug Screen, Item No. PSP-10M
Published December 30, 2015 · Recall initiated: November 16, 2015
Summary
FDA records medical device Class III recall Z-0485-2016, published December 30, 2015 and initiated November 16, 2015. Recalling firm: Ameditech Inc; Status: Terminated; Reported quantity: 240 kits; Lot: 153135 154119. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Ameditech Inc
- Distributor
- Nationwide Distribution.
- Lot
- 153135 154119
- Risk classification
- Class III
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAImmuTest Drugs of Abuse Cup (AMT Item Number/ AMT Description): IMCA-5AB-W / "ImmuTest Drugs of Abuse CupOctober 7, 2020
- FDANoble 1 Step+ Cup (AMT Item Number/ AMT Description): NBCA-13A-B /"Noble 1 Step + Cup" THC50/COC150;October 7, 2020
- FDAFirst Check 7 Panel Drug Cup: (AMP/COC/MDMA/MET/OPI/PCP/THC); AMT Item Number 990100BOctober 7, 2020
- FDADrug Screening Component: Uncut Sheets Part Number/ Description/ LOT Number 100163/ EDI OPI (300) UncutOctober 7, 2020
- FDA1 Step 12 Panel Cup, Item No. NBCA-12M-WDecember 30, 2015
- FDA11 Panel Card (OPI 300) w/Adult, Item No. 71125AADecember 30, 2015
Questions about this recall
Was 10-Panel Pipette Drug Screen, Item No. PSP-10M recalled?
Yes. FDA published recall Z-0485-2016 on December 30, 2015. Reported hazard: Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.
What should I do if I have this product?
Voluntary: Firm initiated · Letter